Actively Recruiting
Co-produced Community Action for Improved Access to Cervical Cancer Screening in Rural Areas of the Mifi Health District
Led by Prof. Patrick Petignat · Updated on 2026-04-14
800
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
Sponsors
P
Prof. Patrick Petignat
Lead Sponsor
U
University Hospital, Geneva
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to improve access to cervical cancer screening for women living in rural areas of the Mifi Health District in Cameroon. Cervical cancer causes a high number of deaths globally, especially in low- and middle-income countries due to low screening rates. The World Health Organization has set a goal for 70% of women to be screened, but this target is not met in Cameroon, particularly in rural communities. The study evaluates community co-produced action (CCA) strategies compared to traditional hospital-based screening approaches to increase screening coverage. The study uses a cluster-randomized design with 14 rural health areas divided into two groups. In the intervention group, participatory workshops with community members and a multidisciplinary team will co-develop local strategies for HPV-based cervical cancer screening, including awareness campaigns, collaboration with community health workers, health education materials, and access improvements. The control group will follow a standard hospital-based screening strategy coordinated by community health workers inviting women to screening at a regional hospital. All screened women will receive free HPV testing, triage, and treatment as needed. Participants will be women aged 30-49 years (25-49 if HIV-positive) living in the specified rural areas. They will be invited to undergo screening, with follow-up assessments including triage for HPV-positive women and treatment when necessary. The study measures the number of women completing screening within 12 months, triage and treatment completion within 6 months, and follow-up visits at 12 months. The study monitors sociodemographic factors and evaluates the effectiveness of community-based strategies in improving screening rates over one year.
CONDITIONS
Brief Title
Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 30-49 years old (25-49 years old if HIV-positive)
- Residency in one of the 14 rural health areas of Mifi health district
- Ability to give signed informed consent
You will not qualify if you...
- Known cervical cancer
- Symptoms compatible with cervical cancer
- Previous hysterectomy
- Terminal disease other than cervical cancer
- Cervical cancer screening test in the last 5 years (3 years if HIV-positive)
- Pregnancy at the time of screening
- Lack of discernment capacity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 months after implementation of the screening strategy at health-area level
Participants are observed following the implementation of cervical cancer screening strategies adapted to their local setting.
Trial Site Locations
Total: 1 location
1
Bafoussam Regional Hospital
Bafoussam, Mifi, Cameroon, 00237
Actively Recruiting
Research Team
A
Ania M Wisniak, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here